Search

Displaying results 691 - 700 of 10000 in total
  1. Drug

    Methotrimeprazine

    go.drugbank.com/drugs/DB01403
    Approved

    A phenothiazine with pharmacological activity similar to that of both chlorpromazine and promethazine. … It has the histamine-antagonist properties of the antihistamines together with central nervous system effects resembling those of chlorpromazine.

    Synonyms: (-)-(2R)-3-(2-methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amineCategories: Analgesics, Non-Narcotic, Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
  2. Drug

    Tolfenamic acid

    go.drugbank.com/drugs/DB09216
    Approved

    [A31824] It was discovered by scientists at Medica Pharmaceutical Company in Finland. It is used in the UK as a treatment for migraine under the name of Clotam. … [L1292] In the US, it presents a Status class I by the FDA. By the European Medicine Agency, it was granted in 2016 with the status of orphan for the treatment of supranuclear palsy.[L1291]

    Categories: Analgesics, Non-Narcotic, Non COX-2 selective NSAIDSProducts: TOLFEDINE 4% W/V SOLUTION FOR INJECTION FOR DOGS AND CATS, Tolfine Solution for Injection 4.0% W/V
  3. Drug

    Quinidine

    go.drugbank.com/drugs/DB00908
    Approved

    However, it continues to be used in the treatment of Brugada syndrome, short QT syndrome and idiopathic ventricular fibrillation.[A250050] … [A38016,A250050] Quinidine is considered the first antiarrhythmic drug (class Ia) and is moderately efficacious in the acute conversion of atrial fibrillation to normal sinus rhythm.

    Synonyms: CIN-QUIN, (R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanolCategories: Compounds used in a research, industrial, or household setting, Antiarrhythmics, Class I
  4. Drug

    Durvalumab

    go.drugbank.com/drugs/DB11714
    ApprovedInvestigational

    [L12624] It is additionally approved in Canada under the same name (Imfinzi) for similar indications, as well as the treatment of patients with locally advanced or metastatic urothelial carcinoma. … [L12621] In September 2018, durvalumab was approved by the EMA for the treatment of adult patients with locally advanced, unresectable non-small cell lung cancer (NSCLC), only if PD-L1 is expressed in

    Products: IMFINZI CONCENTRATE FOR SOLUTION FOR INFUSION 50 MG/ML, IMFINZI CONCENTRATE FOR SOLUTION FOR INTRAVENOUS INFUSION 50 MG/ML
  5. Indication

    Increase in Intracranial Pressure (ICP)

    go.drugbank.com/conditions/DBCOND0113421
    Drugs: Glycerin · Sodium chloride
    Synonyms: Increase in Intracranial Pressure (ICP)
  6. Indication

    Leydig Cell Failure in Adult

    go.drugbank.com/conditions/DBCOND0081825
    Drugs: Mesterolone
    Synonyms: Leydig Cell Failure in Adult, Leydig cell failure in adult (disorder)
  7. Indication

    Burning sensation in the mouth

    go.drugbank.com/conditions/DBCOND0102063
    Drugs: Benzoic acid
    Synonyms: Discomfort in mouth, Burning sensation in the mouth
  8. Indication

    Deficiencies in enzymes of the urea cycle

    go.drugbank.com/conditions/DBCOND0023710
    Drugs: Phenylbutyric acid
    Synonyms: Deficiencies in enzymes of the urea cycle
  9. Indication

    Squamous Cell Carcinoma In-situ (SCC-is)

    go.drugbank.com/conditions/DBCOND0043487
    Drugs: Aminolevulinic acid
    Synonyms: Squamous cell carcinoma in situ, no International Classification of Diseases for Oncology subtype, Squamous cell carcinoma, no International Classification of Diseases for Oncology subtype
  10. Drug

    Betiatide

    go.drugbank.com/drugs/DB14082
    Approved

    Products: Renoscint MAG3 1 mg Kit für ein radioaktives Arzneimittel, Kit for the Preparation of Technetium Tc99m Mertiatide